comparemela.com

AnPac Bio-Medical Science Co. (ANPC) Reports H1'22 Results

AnPac Bio-Medical Science Co. (ANPC) Reports H1'22 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Weitou ,Fujian ,China ,Taiwan ,Shanghai ,United States ,Xiaoyu Li ,Anhui ,Chang Yu ,Hunan ,Guo Feng ,Honggang ,Heilongjiang ,Xing Pu ,Delaware ,Changwei ,Hainan ,Haohan Xu ,Yuyang Cui ,Chris Chang Yu ,Jianhua Shao ,Chris Yu ,Jiawen Kang ,Llctina Xiao ,Ren Luo ,Zhigang Frank Zhao ,Anpac Bio ,Tianruo Robert Pu ,Changwei System Technology Shanghai Co Ltd ,Company American Depositary Shares Adss ,Hunan Weitou Scientific Technology Co Ltd ,Science Co Ltd ,Nasdaq ,Exchange Commission ,Listing Qualifications Department ,Development Expenses ,Delaware Court ,American Association For Cancer Research ,Hearings Panel ,Nasdaq Stock Market ,Securities Exchange ,Company Of The Staff ,Wall Street ,Pac Bio Medical Science ,First Half ,Registered Convertible Debentures ,Ascent Convertible Debentures ,Nasdaq Capital Market ,General Counsel ,Listed Securities ,Listing Rule ,Mandatory Panel Monitor ,American Association ,Cancer Research ,Financial Results ,Anpai Shanghai ,Changwei System Technology ,Shanghai Stonedrop Investment Management ,Co Chief Executive Officer ,Co Chief Financial Officer ,American Depositary Shares ,Chen Wenge ,Stock Repurchase Agreement ,Pac Bio ,Cancer Differentiation Analysis ,Phil Case ,Investor Relationsphone ,Ascent Investor Relations ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Annual Report ,Months Ended June ,

comparemela.com © 2020. All Rights Reserved.